Skip to main content
GNLX logo

Genelux Corporation

GNLXNASDAQHealthcareBiotechnology

$2.42Today:- (-)1Y −56.64%

As of Oct 16, 2026 close

Market cap
$111.50M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.29$8.54
Volume (live)
-
Avg. volume (3M)
264.08K

Genelux (GNLX) Income Statement

Genelux reported revenue of $8.00K in fiscal 2025 (fiscal year ended Dec 31, 2025), flat from $8.00K a year earlier. Genelux posted a net loss of $32.15M, compared with a net loss of $29.87M a year earlier. Gross margin was 100.0% and operating margin -415175.0%.

Genelux Income Statement Analysis

Values in millions USD

Scroll to see more
Genelux Corporation income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Mar 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue0.010.010.170.1711.070.000.000.00
Cost of Revenue0.570.901.02-0.970.900.660.00
Gross Profit0.010.01-0.850.1711.07-0.90-0.660.00
Operating Expenses
Research & Development19.7518.8712.7712.449.086.326.237.53
Selling, General & Administrative13.4812.8311.5711.905.008.296.203.34
Operating Expenses33.2231.7023.3224.3414.0813.7212.4210.87
Operating Income-33.21-31.70-24.17-24.17-3.01-14.61-12.42-10.87
Other Income/Expense
Interest Income1.071.460.240.240.000.000.000.00
Interest Expense0.000.003.97-0.82-1.411.82-1.220.76
Other Income/Expense1.071.83-4.13-4.13-1.09-1.77-1.22-0.76
Income
Income Before Tax-32.15-29.87-28.30-28.30-4.11-16.38-13.64-11.63
Income Tax Expense0.000.000.00-1.100.000.000.00
Net Income-32.15-29.87-28.30-28.30-5.21-17.80-13.64-11.63
Net Income - Continuous Operations-32.15-29.87-28.30-28.30-5.21-17.80-14.86-11.63
Net Income - Discontinued Operations--------
EBITDA-32.97-31.46-26.46-23.67-2.46-13.67-11.87-10.49
EBIT-33.21-31.70--24.17-3.01-14.96-12.42-
Depreciation & Amortization0.570.241.020.500.550.900.550.38
Earnings Per Share
Basic EPS-1.00-1.00-1.00-1.00-1.00-1.00-2.00-
Diluted EPS-1.00-1.00-1.00-1.00-1.00-1.00-2.00-
Basic Shares Outstanding37.1831.4524.4324.439.1223.628.3623.62
Diluted Shares Outstanding37.1831.4524.4324.439.1223.628.3623.62

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Genelux Financial Statements

What was Genelux's revenue in fiscal 2025?

Genelux reported revenue of $8.00K in fiscal 2025 (fiscal year ended Dec 31, 2025). That was flat from $8.00K a year earlier.

Is Genelux profitable?

No. Genelux reported a net loss of $32.15M in fiscal 2025. In fiscal 2024 it lost $29.87M.

What is Genelux's operating margin?

Genelux's operating income was −$33.21M on revenue of $8.00K in fiscal 2025, an operating margin of -415175.0%, compared with -396200.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition